Patents by Inventor Warren Steck

Warren Steck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030096023
    Abstract: The present invention provides tyrosinase inhibiting extracts from dictotyledonous plant species indigenous to Canada and compositions containing the extracts for the treatment of skin, particularly skin lightening. The present invention also provides a method of detecting tyrosinase activity in an extract of a dicotyledonous plant species indigenous to Canada.
    Type: Application
    Filed: December 30, 2002
    Publication date: May 22, 2003
    Inventor: Warren Steck
  • Patent number: 6528490
    Abstract: The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B, may be purified from natural sources, such as plant material (e.g. Epilobium angustifolium).
    Type: Grant
    Filed: November 4, 1999
    Date of Patent: March 4, 2003
    Assignee: Fytoken Products, Inc.
    Inventors: Warren Steck, Mark Hetherington
  • Patent number: 6521267
    Abstract: The present invention provides tyrosinase inhibiting extracts from dictotyledonous plant species indigenous to Canada and compositions containing the extracts for the treatment of skin, particularly skin lightening. The present invention also provides a method of detecting tyrosinase activity in an extract of a dicotyledonous plant species indigenous to Canada.
    Type: Grant
    Filed: April 9, 2001
    Date of Patent: February 18, 2003
    Assignee: Fytokem Prtoducts, Inc.
    Inventor: Warren Steck
  • Publication number: 20030004131
    Abstract: The invention provides medicaments comprising an oenothein, including topical formulations for use as free radical scavengers, or to treat irritation, or to treat inflammation. The oenothein for use in such formulations, such as oenothein-A or oenothein-B, may be purified from natural sources, such as plant material (e.g. Epilobium angustifolium).
    Type: Application
    Filed: November 4, 1999
    Publication date: January 2, 2003
    Inventors: WARREN STECK, MARK HETHERINGTON